Transdermal Drug Delivery System Market Intelligence Report – Global Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery System Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Transdermal Drug Delivery System Market is projected to reach USD 8,478.05 million by 2027 from USD 6,369.32 million in 2021, at a CAGR 4.88% during the forecast period.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

The report on transdermal drug delivery system identifies key attributes about the customer to define the potential market and identify different needs across the industry.

Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience.

This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

Key Findings

• The Americas Transdermal Drug Delivery System Market size was estimated at USD 2,498.05 million in 2021, is expected to reach USD 2,602.91 million in 2022, and is projected to grow at a CAGR of 4.74% to reach USD 3,299.16 million by 2027.
• The Asia-Pacific Transdermal Drug Delivery System Market size was estimated at USD 1,670.92 million in 2021, is expected to reach USD 1,762.80 million in 2022, and is projected to grow at a CAGR of 5.17% to reach USD 2,261.22 million by 2027.
• The Europe, Middle East & Africa Transdermal Drug Delivery System Market size was estimated at USD 2,200.34 million in 2021, is expected to reach USD 2,297.37 million in 2022, and is projected to grow at a CAGR of 4.81% to reach USD 2,917.67 million by 2027.

Company Usability Profiles:

• 3M Company
• Bayers AG
• Boehringer Ingelheim International GmbH
• Endo International, Inc.
• Glaxosmithkline PLC
• Hisamitsu Pharmaceutical Co., Inc.
• IBSA Farmaceutici Italia Srl
• Johnson & Johnson
• Katecho, LLC
• Lavipharm S.A.
• Lead Chemical Co., Ltd.
• Luye Pharma Group
• Manchester BIOGEL
• Nitto Denko Corporation
• Novartis International AG
• Nutriband Inc.
• Sparsha Pharma International Pvt. Ltd.
• UCB S.A.
• Viatris Inc.

Market Segmentation & Coverage:

Type:

• Transdermal Patches
  • Drug-In-Adhesive Patches
  • Matrix Patches
  • Microneedle Patches
  • Reservoir Membrane Patches
• Transdermal Semisolids
  • Gels
  • Ointments
  • Sprays

Application:

• Cardiovascular Diseases
• Central Nervous System Disorders
• Hormonal Applications
• Pain Management
• Transdermal Estrogen Therapy

End User:

• Home Care Settings
• Hospitals & Clinics

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

For more information about this report visit https://www.researchandmarkets.com/r/6mu1n0

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900